The TRANSVAX brand, founded in 2011 (Japan), from 67 sister brands and 17478 competing brands. TRANSVAX is owned by Astellas Pharma, listed on the stock exchange of Francfort The International Securities Identification Number (ISIN) of Astellas Pharma is JP3942400007. TRANSVAX belongs to the Drug Manufacturers business sector.